Answers are grounded in this paper and cite their sources.
Experimental study reveals that polystyrene microplastics trigger vascular endothelial damage via ferroptosis and metabolic dysregulation in mice, highlighting potential cardiovascular risks.
Polystyrene microplastics (PS-MPs) are environmental pollutants linked to cardiovascular diseases. This study investigated PS-MP-induced vascular toxicity mechanisms in mice. Mice were divided into saline control, low/medium/high PS-MP exposure (0.1, 1, and 10 mg/kg/d), and PS-MPs plus ferroptosis inhibitor Ferrostatin-1 (1 mg/kg/d + Fer-1) for 5 weeks. Vascular histopathology, lipid profiles, oxidative stress, ferroptosis markers, endothelial function, and serum metabolomics were assessed. PS-MP exposure elevated ROS, MDA, TC, and TG while reducing GSH and HDL-C. Ferroptosis was confirmed by decreased GPX4 and SLC7A11, with increased Fe 2+ deposition. Vascular endothelial injury and remodeling occurred, evidenced by elevated ET-1, VEGF-A, VCAM-1, and ICAM-1, alongside reduced NO. Metabolomics revealed disruptions in folate, amino acid, citrate cycle, and tryptophan metabolism. Fer-1 inhibited ferroptosis, alleviating endothelial damage and vascular remodeling. PS-MPs induce vascular toxicity through oxidative stress, ferroptosis, and metabolic disturbances, mitigated by Fer-1.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: